Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Alopecia × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 15 Thoracic 2 Genitourinary 2 Dermatologic 2 CNS 2 Other hematologic neoplasm 1 Other 1 Lymphoid 1 Head & Neck 1 Gastrointestinal 1 Endocrine 1

Conditions

Lymphoma 2681 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2207 Lymphoma, Non-Hodgkin 2019 Leukemia, Lymphocytic, Chronic, B-Cell 1776 Lymphoma, Follicular 1631 Lymphoma, Large B-Cell, Diffuse 1588 Leukemia 1213 Hodgkin Disease 1154 Lymphoma, Mantle-Cell 1065 Leukemia, Myeloid, Acute 851 Burkitt Lymphoma 847 Multiple Myeloma 771 Lymphoma, B-Cell, Marginal Zone 749 Recurrence 743 Lymphoma, B-Cell 658 Myelodysplastic Syndromes 603 Neoplasms 525 Lymphoma, T-Cell, Cutaneous 487 Waldenstrom Macroglobulinemia 453 Lymphoma, Large-Cell, Immunoblastic 439 Mycosis Fungoides 391 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 357 Lymphoma, Large-Cell, Anaplastic 346 Sezary Syndrome 328 Hematologic Neoplasms 309 Lymphoma, T-Cell, Peripheral 308 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 296 Myeloproliferative Disorders 290 Neoplasms, Plasma Cell 272 Blast Crisis 253

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00746980 2016-06-14

Efalizumab in the Treatment of Alopecia, Phase II

Northwestern University

Phase 2 Withdrawn

Alopecia, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡